Joshua Rottner

A partner in Goodwin’s Life Sciences group, Josh counsels high-growth life sciences, healthcare and technology companies from their formation through an initial public offering or M&A exit. Josh often serves as his clients’ outside general counsel, advising them on startup and formation matters, corporate governance, financing transactions, mergers and acquisitions, and other strategic transactions, working closely with his clients’ management teams and boards of directors to achieve their strategic goals.

In addition, Josh has extensive experience representing venture capital and growth equity funds in their portfolio company investments and acquisitions in the healthcare and technology industries. He also advises public companies in public offerings, Securities and Exchange Commission periodic reporting and compliance, and M&A transactions.

JD Boston College Law School 2008; BA Bates College 2001